bioMérieux S.A.

bioMérieux S.A.

World Rank (Jan-05-2024)
1,355
Market Cap (Jan-05-2024)
12.841 Billion USD
World Rank (Jul-30-2023)
1,364
Market Cap (Jul-30-2023)
12.835 Billion USD
World Rank (Jan-07-2022)
1,322
Market Cap (Jan-07-2022)
15.281 Billion USD
World Rank (Jan-01-2021)
1,071
Market Cap (Jan-01-2021)
16.798 Billion USD
Company Rank in Country in 2023
Rank in France in July-2023 is 37
Headquarters Country
France
CEO
Alexandre Merieux
Employee Count
13,000
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
3,957 Million USD
Annual Operating Income in USD
731 Million USD
Annual Net Income in USD
498 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
5,718 Million USD
Total Liabilities in USD
1,701 Million USD
Total Equity in USD
4,016 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
Biotechnology
Technology
HealthCare Products
Company Website
BIOMERIEUX
Wikipedia
Wikipedia
Yahoo
Yahoo
Company Profile

Biotechnology company with headquarters is in France.

Annual Results Summary

BIOMERIEUX - Yearly Revenue and Net Income - in Million EUR:

Year - EndingRevenueOperating IncomeNet Income
Dec-20223,589663452
Dec-20213,376801601
Dec-20203,118595404
Dec-20192,674388272
Dec-20182,421361256
Balance Sheet Summary

Total Assets as on Dec-2022 was 5,186 Million EUR.

Total Liabilities as on Dec-2022 was 1,543 Million EUR.

Total Equity as on Dec-2022 was 3,642 Million EUR.

Founded Year
1963
ISIN Code
FR0013280286
Stock Category
EURONEXT 100
Stock Exchange
EURONEXT
Company SubCategory
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe

Share